Samad Muhammadnejad

5PUBLICATIONS
4CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 27, 2024
Unwanted disorders and xenogeneic graft-versus-host disease in experimental immunodeficient mice: How to evaluate and how to report.

Seyed Mostafa Monzavi, Samad Muhammadnejad, Vahid Mansouri

|Sep 22, 2023
Cytotoxicity of WT1-reactive T cells against Wilms tumor: An implication for antigen-specific adoptive immunotherapy.

Seyed Mostafa Monzavi, Amir Ali Hamidieh, Mohammad Vasei

|Jun 21, 2022
Spontaneous xenogeneic GvHD in Wilms' tumor Patient-Derived xenograft models and potential solutions.

Seyed Mostafa Monzavi, Ahad Muhammadnejad, Maryam Behfar

|Apr 20, 2022
Adoptive NK-cell transfer as a potential treatment paradigm for Wilms tumor: A preclinical study.

Maryam Behfar, Samad Muhammadnejad, Shahrokh Abdolahi

|May 04, 2021
Characterization of a xenograft model for anti-CD19 CAR T cell studies.

N Ahmadbeigi, S Alatab, M Vasei

Pageof 1